Matthew L. Rizk
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 20
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 25
- Virology top 5%
- HIV Research and Treatment 8
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 12
-
- Pneumonia and Respiratory Infections 15
-
- Microbial Metabolic Engineering and Bioproduction 6
-
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- James C. LiaoLinh M. TranElizabeth G. RheeKatherine YoungMallika LalaLing ZouAmanda PaschkeMaria C Losada
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Matthew L. Rizk
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Applied Microbiology and Biotechnology 267
- Molecular Medicine 591
- Pharmacology 644
- Virology 114
- Infectious Diseases 274
Countries citing papers authored by Matthew L. Rizk
This map shows the geographic impact of Matthew L. Rizk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Rizk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Rizk more than expected).
Fields of papers citing papers by Matthew L. Rizk
This network shows the impact of papers produced by Matthew L. Rizk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Rizk. The network helps show where Matthew L. Rizk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew L. Rizk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 6 | |
| 5 | 2021 | 27 | |
| 6 | 2020 | 13 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 35 | |
| 10 | 2018 | 11 | |
| 11 | 2016 | 2 | |
| 12 | 2016 | 25 | |
| 13 | 2015 | 13 | |
| 14 | 2015 | 24 | |
| 15 | 2015 | 12 | |
| 16 | 2014 | 35 | |
| 17 | 2010 | 11 | |
| 18 | 2009 | 57 | |
| 19 | 2009 | 46 | |
| 20 | 2008 | 191 |
About Matthew L. Rizk
Matthew L. Rizk is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Virology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (20 papers), Pneumonia and Respiratory Infections (15 papers), HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers), Microbial Metabolic Engineering and Bioproduction (6 papers), Antibiotic Use and Resistance (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (267 citations), Molecular Medicine (591 citations) and Pharmacology (644 citations). Matthew L. Rizk has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include James C. Liao, Linh M. Tran, Elizabeth G. Rhee, Katherine Young, Mallika Lala, Ling Zou, Amanda Paschke, Maria C Losada, Joan R. Butterton and Nicholas A. Kartsonis. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.